Related Experiment Video
Updated: Aug 5, 2026

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
Published on: February 8, 2017
Shear-Responsive Red Blood Cell Carriers for Targeted Drug Delivery to Constricted Arteries
Danielle Nemcovsky Amar1, Rukiye Tuna2, Tirosh Mekler1
1Department of Biomedical Engineering, Technion Israel Institute of Technology, Technion City, Haifa, Israel.
Shear-responsive red blood cells (sr-RBCs) release drugs specifically at artery constrictions. These engineered cells maintain integrity and function, offering a novel approach for vascular disease treatment.
Area of Science:
- Biophysics
- Biomaterials
- Cardiovascular Research
Background:
- Red blood cells (RBCs) are explored as natural drug delivery vehicles due to their biocompatibility and circulation time.
- Targeted drug delivery to stenotic arteries remains a significant clinical challenge.
Purpose of the Study:
- To investigate the use of shear-responsive RBCs (sr-RBCs) for mechanical drug release at arterial constrictions.
- To evaluate the biophysical properties and in vivo-like behavior of sr-RBCs under flow conditions.
Main Methods:
- Engineering RBCs to be shear-responsive for controlled cargo release.
- Perfusion studies using stenotic arterial models and microfluidic capillary networks.
- Multiscale modeling of RBC suspension fluid dynamics and membrane stretching.
Main Results:
- sr-RBCs demonstrated shear-dependent drug release exclusively in constricted arterial models.
- No drug release occurred in unconstricted vessels, preserving membrane integrity and CD47 expression.
- sr-RBCs successfully navigated microvascular networks without premature cargo release.
Conclusions:
- sr-RBCs offer a targeted drug delivery mechanism triggered by mechanical forces in stenotic arteries.
- This biophysical strategy shows promise for treating vascular constrictions and related diseases.
- Mechanosensitive cell carriers represent a novel therapeutic avenue for cardiovascular conditions.
More Related Videos
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

